These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16563279)

  • 1. [The safety and efficacy of Cypher drug-eluting stent: results from a six months follow-up study in patients with ST-segment elevation myocardial infarction].
    Yang XC; Wang LF; Li WM; Ge YG; Wang HS; Zou YC; Xu L; Ni ZH; Lian Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1099-101. PubMed ID: 16563279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term efficacy of sirolimus-eluting stents (Cypher) versus bare metal stents for patients with ST-segment elevation myocardial infarction].
    Ge YG; Zhang DP; Yang XC; Wang LF; Wang HS; Li WM; Xu L; Ni ZH; Lian Y; Xue YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):108-12. PubMed ID: 19099944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy comparison of primary percutaneous coronary intervention with biodegradable polymer- and durable polymer-based sirolimus-eluting stents for patients with acute myocardial infarction].
    Li Q; Wang LF; Yang XC; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Xia K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct; 38(10):886-90. PubMed ID: 21176630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction.
    Gao H; Yan HB; Zhu XL; Li N; Ai H; Wang J; Li SY; Yang D
    Chin Med J (Engl); 2007 May; 120(10):863-7. PubMed ID: 17543174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
    Violini R; Musto C; De Felice F; Nazzaro MS; Cifarelli A; Petitti T; Fiorilli R
    J Am Coll Cardiol; 2010 Feb; 55(8):810-4. PubMed ID: 20170821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G; Saia F; Percoco G; Manari A; Santarelli A; Vignali L; Varani E; Benassi A; Sangiorgio P; Tarantino F; Magnavacchi P; De Palma R; Guastaroba P; Marzocchi A
    Int J Cardiol; 2010 Apr; 140(2):154-60. PubMed ID: 19056134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
    Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY;
    Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
    J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction.
    Jimenez-Valero S; Santos B; Pajin F; Canton T; Lazaro E; Moreu J; Hernandez G; Padial LR
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):492-7. PubMed ID: 17896411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up.
    Palmieri C; Ravani M; Trianni G; Gianetti J; Vaghetti M; Rizza A; Paradossi U; Beqiri A; Berti S
    J Invasive Cardiol; 2010 Apr; 22(4):151-8. PubMed ID: 20351384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
    Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center.
    Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW
    Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).
    Lim SY; Park HW; Chung WY; Kim SY; Kim KS; Bae JW; Youn TJ;
    J Invasive Cardiol; 2012 Jun; 24(6):270-3. PubMed ID: 22684380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.